Objective.
The aim of this study
was to compare impulsivity and risky decision making among HIV-positive and negative
heroin dependent persons.
Methods.
We compared different
dimensions of impulsivity and risky decision making in two groups of 60 HIV-positive
and 60 HIV-negative male heroin dependent persons. Each group was comprised of equal
numbers of current (treatment seeker) and former (abstinent) heroin addicts. Data
collection tools included Balloon Analogue Risk Task (BART), Iowa Gambling Task
(IGT), Barratt Impulsiveness Scale (BIS), and Zuckerman Sensation Seeking Scale
(SSS).
Results.
In SSS, comprised
of four subscales including thrill and adventure seeking (TAS), experience seeking
(ES), disinhibition (DIS), and boredom susceptibility (BS), there was a borderline
difference in DIS (P = 0.08) as HIV-positive group scored higher than HIV-negative
group. Also, ES and total score were significantly higher among HIV-positive patients.
In BART, HIV-positive subjects scored higher in risk taking than HIV-negative subjects
as reflected in higher Average Number of puffs in Successful Balloons (ANSB). In
BIS, HIV-positive group scored significantly higher in cognitive impulsivity (CI)
(P = 0.03) and nonplanning impulsivity (NPI) (P =
0.05) in comparison to HIV-negative group. Also, current heroin addicts scored significantly
higher in NPI compared to former addict HIV-negative participants (P =
0.015). IGT did not show any significant difference between groups.
Conclusion.
Higher levels of impulsivity
and risk taking behaviors among HIV-positive heroin addicts will increase serious
concerns regarding HIV transmission from this group to other opiate dependents and
healthy people.
Item∗ | HIV-positive group | HIV-negative group | P value♦ |
---|---|---|---|
Zuckerman Sensation Seeking Scale (SSS) | |||
Thrill and adventure seeking | 6.70 ± 2.80 | 6.33 ± 2.55 | 0.45 |
Experience seeking | 4.28 ± 1.90 | 3.30 ± 2.03 | 0.007 |
Disinhibition | 3.52 ± 1.65 | 2.95 ± 1.89 | 0.083 |
Boredom susceptibility | 2.70 ± 1.65 | 2.48 ± 1.44 | 0.44 |
SSS total score | 17.20 ± 5.75 | 15.07 ± 5.13 | 0.03 |
Balloon Analogue Risk Task (BART) | |||
Average Number of puffs in Successful Balloons | 34.58 ± 17.11 | 25.15 ± 13.35 | 0.002 |
Number of Successful Balloons | 17.52 ± 4.02 | 22.63 ± 4.00 | <0.001 |
Average Number of puffs in Each Balloon | 30.40 ± 12.40 | 23.64 ± 11.58 | 0.004 |
Barratt Impulsiveness Scale (BIS) | |||
Nonplanning impulsivity | 28.38 ± 4.10 | 26.75 ± 4.99 | 0.053 |
Motor impulsivity | 24.43 ± 5.04 | 24.57 ± 6.51 | 0.9 |
Cognitive impulsivity | 19.47 ± 4.27 | 17.67 ± 4.94 | 0.035 |
BIS total score | 72.25 ± 10.67 | 69.08 ± 14.02 | 0.16 |
Iowa Gambling Task (IGT) | |||
Total duration of IGT (seconds) | 286.54 ± 168.38 | 314.54 ± 144.77 | 0.38 |
Net amount of win (win − loss) | −12667.50 ± −11223.32 | −14242.93 ± 14446.33 | 0.55 |
IGT total score [(C + D)−(A + B)] | −2.56 ± 21.54 | −5.65 ± 29.38 | 0.55 |
∗Data are represented as mean ± SD.
♦Independent sample t-test.
Full article at: http://goo.gl/SKfpj0
By: Koosha
Paydary, 1 , 2 , 3 Somayeh
Mahin Torabi, 2 SeyedAhmad
SeyedAlinaghi, 1 Mehri
Noori, 2 Alireza
Noroozi, 4 , 5Sara Ameri, 1 , 2 , 3 and Hamed
Ekhtiari 2 , 6 , *
1Iranian Research Center for HIV/AIDS
(IRCHA), Iranian Institute for Reduction of High-Risk Behaviors, Tehran
University of Medical Sciences (TUMS), Tehran, Iran
2Neurocognitive Laboratory, Iranian
National Center for Addiction Studies (INCAS), Tehran University of Medical
Sciences (TUMS), Tehran, Iran
3Students' Scientific Research Center
(SSRC), Tehran University of Medical Sciences (TUMS), Tehran, Iran
4School of Advanced Technologies in
Medicine (SATiM), Tehran University of Medical Sciences (TUMS), Tehran, Iran
5Head of Substance Abuse Prevention and
Treatment Office (SAPTO), Mental Health, Social Health and Addiction Department
(MeHSHAD), Ministry of Health and Medical Education (MoHME), Tehran, Iran
6Translational Neuroscience Program,
Institute for Cognitive Science Studies (ICSS), Tehran University of Medical
Sciences (TUMS), Tehran, Iran
More at: https://twitter.com/hiv insight
No comments:
Post a Comment